Home

druer Utenkelig anker nature parkinson s disease mann lover selger

Inflammation and immune dysfunction in Parkinson disease | Nature Reviews  Immunology
Inflammation and immune dysfunction in Parkinson disease | Nature Reviews Immunology

Olfactory dysfunction in Parkinson disease | Nature Reviews Neurology
Olfactory dysfunction in Parkinson disease | Nature Reviews Neurology

Failure of the ubiquitin–proteasome system in Parkinson's disease | Nature  Reviews Neuroscience
Failure of the ubiquitin–proteasome system in Parkinson's disease | Nature Reviews Neuroscience

Parkinson's disease - The Lancet
Parkinson's disease - The Lancet

Parkinson's disease as a system-level disorder | npj Parkinson's Disease
Parkinson's disease as a system-level disorder | npj Parkinson's Disease

Goal-directed and habitual control in the basal ganglia: implications for Parkinson's  disease | Nature Reviews Neuroscience
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience

Non-motor features of Parkinson disease | Nature Reviews Neuroscience
Non-motor features of Parkinson disease | Nature Reviews Neuroscience

Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease |  Nature Communications
Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease | Nature Communications

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Mice with disrupted mitochondria used to model Parkinson's disease
Mice with disrupted mitochondria used to model Parkinson's disease

Parkinson disease and the immune system — associations, mechanisms and  therapeutics | Nature Reviews Neurology
Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology

Non-motor features of Parkinson disease | Nature Reviews Neuroscience
Non-motor features of Parkinson disease | Nature Reviews Neuroscience

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β  pathologies | Nature Reviews Neuroscience
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Genetics of Parkinson disease: paradigm shifts and future prospects | Nature  Reviews Genetics
Genetics of Parkinson disease: paradigm shifts and future prospects | Nature Reviews Genetics

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Defects in trafficking bridge Parkinson's disease pathology and genetics |  Nature
Defects in trafficking bridge Parkinson's disease pathology and genetics | Nature

The two-century journey of Parkinson disease research | Nature Reviews  Neuroscience
The two-century journey of Parkinson disease research | Nature Reviews Neuroscience

Advances in markers of prodromal Parkinson disease | Nature Reviews  Neurology
Advances in markers of prodromal Parkinson disease | Nature Reviews Neurology

Motor and non-motor circuit disturbances in early Parkinson disease: which  happens first? | Nature Reviews Neuroscience
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience

Parkinson's disease - The Lancet
Parkinson's disease - The Lancet